Research Programs

The UVA Cancer Center has approximately 220 full and associate members divided into five research programs. Each of these programs represents an area of expertise important for understanding how cancer starts and progresses and for development of interventions to detect, diagnose, treat, and prevent cancer. Each program has a natural affinity and identity, with sub-groups that make sense scientifically. In addition, each of these programs has helped generate major discoveries important for cancer:

  • The Cancer Biology Program supports research focused on identification and validation of targets, development of small molecule modulators of validated targets, and elucidating mechanisms, particularly signaling networks, driving cancer.
  • The Cancer Control and Population Health Program conducts population-based research to identify cancer risk, reduce cancer risk and develop systems to support cancer survivors.
  • The Cancer Therapeutics Program supports preclinical science and validation of therapeutic targets leading to investigator-initiated clinical trials for cancer diagnosis, imaging, therapy or survivorship.
  • The Molecular Genetics and Epigenetics Program was the origin of the discovery of the "histone code" and is nationally regarded as a premiere program for the study of chromatin and epigenomics.
  • The Unaligned Research Program includes members of the Cancer Center research program who provide key contributions, but their work is not easily aligned with any of the core programs listed above.

Cancer Research Events

Apr 09 GI Translational Meeting

[Zoom] Presenters: David Wotton, Todd Bauer, David Kashatus; Topic: Development of human PDX models of colorectal cancer to exploit changes in SCFA…

Apr 10 Cancer Immunology Labs Group Meeting

[Zoom Meeting] Presentation

Apr 23 GI Translational Meeting

[Zoom] Presenter: Tom Loughran

May 01 Cancer Immunology Labs Group Meeting

[Zoom Meeting] Presentation

May 08 Cancer Immunology Labs Group Meeting

[Zoom Meeting] Presentation

May 14 Molecular Tumor Board

[ECCCC Room 3303]

Jun 04 Hematopoiesis and Hematology Malignancy Working Group

[West Complex 6191] Michael Engel, MD

Jun 11 Molecular Tumor Board

[ECCC Room 3303]